Serotonin modulation of cerebral glucose metabolism: Sex and age effects

Synapse

Volumn 66, Issue 11, 2012, Pages 955-964

  Munro, Cynthia A ^a   Workman, Clifford I ^a   Kramer, Elisse ^b   Hermann, Carol ^b   Ma, Yilong ^c   Dhawan, Vijay ^c   Chaly, Thomas ^c   Eidelberg, David ^c   Smith, Gwenn S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Aging; Citalopram; Glucose metabolism; Positron emission tomography; Selective serotonin reuptake inhibitors; Serotonin; Sex differences

Indexed keywords

CITALOPRAM; FLUORODEOXYGLUCOSE F 18; PLACEBO; SEROTONIN;

ADULT; AGED; AGING; ARTICLE; BRAIN METABOLISM; BRAIN REGION; FEMALE; GLUCOSE METABOLISM; GRAY MATTER; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; LIFESPAN; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; BRAIN; CITALOPRAM; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS;

EID: 84866145152     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21590     Document Type: Article

References (52)

1. Adams KH, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haugbøl S, Madsen K, Frøkjaer V, Martiny L, Paulson OB, Knudsen GM. 2004. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: Normative data and relationship to physiological and demographic variables. Neuroimage 21: 1105-1113.
2. Alexopoulos G, Katz IR, Reynolds CFIII, Carpenter D, Docherty JP. 2001. Expert consensus panel for pharmacotherapy of depressive disorders in older patients. Postgrad Med Spec Report 1-86.
3. Bartlett EJ, Brodie JD, Wolf AP, Christman DR, Laska E, Meissner M. 1988. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cerebr Blood Flow Metab 8: 502-512.
4. Bethea CL, Smith AW, Centeno ML, Reddy AP. 2011. Long-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques. Neuroscience 192: 675-688.
5. Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, Goldman S. 1996. Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett 204: 25-28.
6. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA. 2005. Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25: 7709-7717.
7. Costes N, Merlet I, Ostrowsky K, Faillenot I, Lavenne F, Zimmer L, Ryvlin P, Le Bars D. 2005. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 46: 1980-1989.
8. Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R. 1998. Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764-775.
9. First M, Spitzer R, Gibbon M, Williams J. 1995. Structured clinical interview for DSM-IV axis 1 disorders-patient edition (SCID-I/P). New York: New York Psychiatric Institute:.
10. Fletcher PC, Frith CD, Baker SC, Shallice T, Frackowiak RS, Dolan RJ. 1995. The mind's eye-Precuneus activation in memory-related imagery. Neuroimage 2: 195-200.
11. 11C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: A positron emission tomography study. Psychiatry Res Neuroimaging 183: 157-166.
12. Frøkjaer VG, Erritzoe D, Madsen J, Paulson OB, Knudsen GM. 2009. Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding. Neuroscience 163: 640-645.
13. Friston KJ, Ashburner J, Kiebel SJ, Nichols TE, Penny WD. 2007. Statistical parametric mapping: The analysis of functional brain images. London, UK: Academic Press.
14. Goldberg S, Smith GS, Barnes A, Ma Y, Kramer E, Robeson K, Kirschner M, Pollock BG, Eidelberg D. 2004. Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol Aging 25: 167-174.
15. Golembiowska K, Dziubina A. 2000. Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 52: 441-448.
16. Henderson JA, Bethea CL. 2008. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 33: 285-293.
17. Hilgert M, Buchholzer M, Jeltsch H, Kelche C, Cassel JC, Klein J. 2000. Serotonergic modulation of hippocampal acetylcholine release after long-term neuronal grafting. Neuroreport 11: 3063-3065.
18. Invernizzi R, Velasco C., Bramante M, Longo A, Samanin R. 1997. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36: 467-473.
19. Jovanovic H, Cerin A, Karlsson P, Lundberg J, Halldin C, Nordström AL. 2006. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 148: 185-193.
20. Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, Halldin C, Nordström AL. 2008. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 39: 1408-1419.
21. Jovanovic H, Karlsson P, Cerin A, Halldin C, Nordström AL. 2009. 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET. Psychiatry Res 172: 31-37.
22. Kapitany T, Schindl M, Schindler SD, Hesselmann B, Füreder T, Barnas C, Sieghart W, Kasper S. 1999. The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res 88: 75-88.
23. Kuikka JT, Tammela L, Bergström KA, Karhunen L, Uusitupa M, Tiihonen J. 2001. Effects of ageing on serotonin transporters in healthy females. Eur J Nucl Med 28: 911-913.
24. Liotti M, Mayberg HS, Brannan SK, McGinnis S, Jerabek P, Fox PT. 2000. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: Implications for affective disorders. Biol Psychiatry 48: 30-42.
25. Lucki I. 1998. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44: 151-162.
26. Liu Y, Yoo MJ, Savonenko A, Stirling W, Price DL, Borchelt DR, Mamounas L, Lyons WEBlue ME, Lee MK. 2008. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci 28: 13805-13814.
27. Lucas G, De Deurwaerdere P, Porras G, Spampinato U. 2000. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Neuropharmacology 39: 1984-1995.
28. Marek GJ, Aghajanian GK. 1998. The electrophysiology of prefrontal serotonin systems: Therapeutic implications for mood and psychosis. Biol Psychiatry 44: 1118-1127.
29. Mateo Y, Ruiz-Ortega JA, Pineda J, Ugedo L, Meana JJ. 2000. Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo. Neuropharmacology 39: 2036-2043.
30. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE. 1981. Quantitation in positron emission tomography. V. Physical-anatomical effects. J Comput Assist Tomogr 5: 734-743.
31. Meltzer C, Smith G, DeKosky S, Mathis C, Pollock B, Moore R, Kupfer D, Reynolds C. 1998a. Serotonin in aging, late life depression, and Alzheimer's disease: The emerging role of functional imaging. Neuropsychopharmacology 18: 407-430.
32. Meltzer CC, Smith G, Price JC, Reynolds CFIII, Mathis CA, Greer P, Lopresti, B, Mintun MA, Pollock BG, Ben-Eliezer D, Cantwell MN, Kaye W, DeKosky ST. 1998b. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: Persistence of effect after partial volume correction. Brain Res 813: 167-171.
33. Møller M, Jakobsen S, Gjedde A. 2007. Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans. Neuropsychopharmacology 32: 1707-1714.
34. Moses-Kolko EL, Price JC, Shah N, Berga S, Sereika SM, Fisher PM, Coleman R, Becker C, Mason NS, Loucks T, Meltzer CC. 2011. Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population. Neuropsychopharmacology 36: 2729-2740.
35. Nishizawa SS, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M. 1997. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94: 5308-5313.
36. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V, Mann JJ. 2002. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954: 173-182.
37. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM. 2010. Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab 30: 1682-1706.
38. Rosa-Neto P, Benkelfat C, Sakai Y, Leyton M, Morais JA, Diksic M. 2007. Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect. Eur J Nucl Med Mol Imaging 34: 1254-1264.
39. 11C]methyl-L-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 33: 815-824.
40. Sanchez RL, Reddy AP, Centeno ML, Henderson JA, Bethea CL. 2005. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res Mol Brain Res 135: 194-203.
41. Sheline YI, Mintun MA, Moerlein SM, Snyder AZ. 2002. Greater loss of 5-HT(2A) receptors in midlife than in late life. Am J Psychiatry 159: 430-435.
42. Smith GS, Kramer E, Hermann CR, Goldberg S, Ma Y, Dhawan V, Barnes A, Chaly T, Belakhleff A, Laghrissi-Thode F, Greenwald B, Eidelberg D, Pollock BG. 2002a. Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatric Psychiatry 10: 715-723.
43. Smith GS, Ma Y, Dhawan V, Gunduz H, Carbon M, Kirshner M, Larson J, Chaly T, Belakhleff A, Kramer E, Greenwald B, Kane JM, Laghrissi-Thode F, Pollock BG, Eidelberg D. 2002b. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 45: 105-112.
44. Smith GS, Lotrich F, Malhotra A, Lee A, Ma Y, Kramer E, Gregersen P, Eidelberg D, Pollock B. 2004. The effect of serotonin transporter polymorphisms on serotonin function. Neuropsychopharmacology 29: 2226-2234.
45. Smith GS, Kramer E, Hermann C, Ma Y, Dhawan V, Chaly T, Eidelberg D. 2009. Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry 66: 259-266.
46. Smith GS, Workman CI, Kramer E, Hermann CR, Ginsberg R, Ma Y, Dhawan V, Chaly T, Eidelberg D. 2011. The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome. Am J Geriatr Psychiatry 19: 53-63.
47. Soloff PH, Price JC, Mason NS, Becker C, Meltzer CC. 2010. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Res: Neuroimaging 181: 77-84.
48. 123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41: 275-284.
49. Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien LK, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R. 2008. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging 35: 2159-2168.
50. Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, Pratley RE, Lawson M, Reiman EM, Ravussin E. 1999. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 96: 4569-4574.
51. Yamamoto M, Suhara T, Okubo Y, Ichimiya T, Sudo Y, Inoue M, Takano A, Yasuno F, Yoshikawa K, Tanada S. 2002. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci 71: 751-757.
52. Zheng P. 2009. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 89: 134-152.